ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

GDR Genedrive Plc

3.50
-0.375 (-9.68%)
08 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Genedrive Plc LSE:GDR London Ordinary Share GB00B1VKB244 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.375 -9.68% 3.50 3.25 3.75 3.875 3.375 3.88 5,099,462 16:28:07
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Coml Physical, Biologcl Resh 55k -5.15M -0.0447 -0.78 4.03M
Genedrive Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker GDR. The last closing price for Genedrive was 3.88p. Over the last year, Genedrive shares have traded in a share price range of 2.75p to 25.75p.

Genedrive currently has 115,139,946 shares in issue. The market capitalisation of Genedrive is £4.03 million. Genedrive has a price to earnings ratio (PE ratio) of -0.78.

Genedrive Share Discussion Threads

Showing 3276 to 3295 of 25375 messages
Chat Pages: Latest  139  138  137  136  135  134  133  132  131  130  129  128  Older
DateSubjectAuthorDiscuss
05/8/2020
17:42
Neither have I, and it is frustrating to see the share price action today, but yesterday's news was such a relief now that all we have to do is wait.
ihavenoclue
05/8/2020
17:01
Cheers .... I've no intension of selling before 200 Will evaluate then. Thanks
amaretto1
05/8/2020
16:59
Amaretto, chill. Yesterday showed what GDR have been doing behind the scenes and partnering with a large US Pharm is a top move.GDR can't control the share price so let's see where we are in 6 weeks when validation is complete, and approvals have landed, and sales from the other 10 countries are known.Chin up and keep the faith.RegardsIHNC
ihavenoclue
05/8/2020
11:50
anyone of the 10,000,000 out there!
abbynat
05/8/2020
11:10
British Airways will soon be testing all passengers and crew . . . I wonder who's kit they'll go for?
suze66
05/8/2020
09:13
i'm hoping OCT!
abbynat
05/8/2020
08:20
Just picked up some more, methinks this will be through the previous high of 300p by the year end.
czar
05/8/2020
08:10
Hope it is back to £2 or more in 6 weeks time.
deanmatlazin
04/8/2020
21:52
Iam thanks for asking !
amaretto1
04/8/2020
21:15
Amar knows everything about every company!!!!
Why is he not in the Bahamas living the life!!

nodoe
04/8/2020
17:29
good folk on here, the poster AMARETTO1 is a SCUMBAG, he goes on the avct bb to flog this share, bad form if you ask me, it's just not cricket.
In summary, he is a bad egg.

lukead
04/8/2020
16:58
Totally correct !!! AVCT is a short not a long
amaretto1
04/8/2020
16:13
Losses.... Your own name on the stock market
ihavenoclue
04/8/2020
15:49
You haven't a clue... your own words
losses
04/8/2020
14:44
Losses
4 Aug '20 - 14:10 - 1611 of 1611
0 0 0
Invested both..

'plonker'

ihavenoclue
04/8/2020
14:10
Invested both..
losses
04/8/2020
12:40
nice post mate. Fascinating link with Beckman's already listed piece.....have people picked up on that yet?
qs99
04/8/2020
12:31
Make money on AVACTA. I bought this morning because they are using Saliva as testing now and should be immediate result.

Genedrive has already completed initial evaluation of Beckman Coulter's RNA extraction chemistry to confirm compatibility with the Genedrive 96 SARS-CoV-2 test. Further work is ongoing to validate clinical saliva samples which are a very relevant sample type for applications such as high volume occupational screening. Beckman's RNAdvance Viral XP has already been listed as an extraction method for swab samples for use with the Centers for Disease Control's EUA-authorized COVID-19 test in FDA's FAQ on testing for SARS-CoV-2.


Personally I think GeneDrive will get saliva test approved in 6 weeks time. We will see who is the winner ….. Genedrive ( £50m market cap ) vs Avacta. ( £322m )


I think Genedrive will come out on top..

deanmatlazin
04/8/2020
12:26
They arennt listed on the USA or am I missing something!
billthebank
04/8/2020
12:18
market makers shaking this for stock they know this will shoot up this afternoon its not even started yet.
datait
Chat Pages: Latest  139  138  137  136  135  134  133  132  131  130  129  128  Older

Your Recent History

Delayed Upgrade Clock